ARM Annual Report & Sector Year in Review: 2019
The 2019 ARM Annual Report provides an overview of the organizations events, publications, and policy initiatives over the last year, with commentary from ARM members. In addition, the report contains a global sector overview detailing industry-specific statistics compiled from hundreds of cell therapy, gene therapy, tissue engineering, and other regenerative medicine therapeutic developers worldwide, including total financings, partnerships and other deals, and clinical trial information.
Regenerative Medicine / Advanced Therapies
Companies based in Europe/Israel
Highest Year for European Financings on Record
2nd Highest Year on Record
Highest Year on Record
Highest Year on Record
Clinical Trials
Sponsored by a European or Israeli developer as of the end of 2019
